Melatonin Safety Concerns: Recalls, Dosage Risks, and Heart Health
Melatonin Heart Failure: Reports, Recalls, and What Consumers Should Do in {{CURRENT_YEAR}}
RecallTracker tracks {{RECALL_COUNT}} recalls from {{AGENCY_COUNT}} agencies across {{COUNTRY_COUNT}} countries; the FDA has issued {{FDA_COUNT}} recalls and the CPSC has issued {{CPSC_COUNT}} recalls. In {{RECALLS_2025}}, agencies issued {{RECALLS_2025}} recall actions, and so far in {{CURRENT_YEAR}} there have been {{RECALLS_2026_YTD}} recall notices recorded by our system. Those numbers matter when assessing safety signals tied to dietary supplements such as melatonin, because product quality problems (mislabeling, contamination, packaging defects) can produce adverse events that mimic or worsen cardiac conditions.
The search term "melatonin heart failure" reflects two separate but related concerns: (1) clinical questions about whether melatonin can cause or worsen heart failure and (2) product-safety concerns — recalls, contamination, and mislabeling — that could indirectly affect people with heart disease. The sections below separate physiology and clinical evidence from recall and surveillance patterns, then give a step-by-step checklist for consumers who have a melatonin product and cardiac risk.
Melatonin and Cardiac Physiology: mechanisms that could affect heart failure risk
Melatonin is an endogenous hormone produced by the pineal gland that entrains circadian rhythms through MT1 and MT2 receptors. Those same receptors and downstream signaling pathways are present in cardiovascular tissue, which creates biological plausibility for both benefit and harm.
How melatonin can influence the heart
Blood pressure regulation: Melatonin contributes to nocturnal blood pressure dipping in many people. When taken as a supplement, melatonin can lower nighttime blood pressure in some studies. For people with marginal perfusion or labile blood pressure, an additional antihypertensive effect could be symptomatic (dizziness, lightheadedness) and—rarely—clinically significant.
Heart rate and autonomic balance: Melatonin modulates autonomic tone. In sensitive individuals or when combined with other central nervous system depressants, melatonin can promote bradycardia or increased vagal tone.
Antioxidant and anti-inflammatory activity: Preclinical models show melatonin can reduce oxidative stress and limit ischemia–reperfusion injury. Several animal studies report improved myocardial function after melatonin in models of cardiac injury; translating those effects into routine clinical use has not occurred.
Electrophysiologic effects: Melatonin has been examined for antiarrhythmic and proarrhythmic potential in isolated models. The human data are limited and inconsistent; isolated case reports suggest arrhythmia temporally associated with melatonin in patients with underlying conduction disease, but causality is not established.
What randomized trials and observational studies show
Trial size and scope: Large randomized controlled trials specifically testing melatonin as a contributor to heart failure or as a therapy for heart failure are lacking. Most human data are small single-center studies or observational reports.
Signal strength: The preclinical literature mostly supports potential cardioprotective effects, but the human safety signal for melatonin causing de novo heart failure is weak. Reported cardiovascular adverse events after melatonin tend to be idiosyncratic (palpitations, transient bradycardia, hypotension) and often involve polypharmacy or underlying cardiac disease.
Special populations: Older adults, people with symptomatic heart failure, and those on multiple cardiac medications (especially agents that influence heart rate or blood pressure) are biologically plausibly more vulnerable to hemodynamic effects from melatonin supplementation.
Clinical implications for people with heart failure
No high-quality evidence shows melatonin causes chronic heart failure in previously healthy persons. However, because melatonin can alter heart rate and blood pressure and because supplement formulations vary, people with heart failure should discuss melatonin use with their cardiologist.
Monitor vital signs: If a clinician approves a trial of melatonin, check blood pressure and heart rate at the times you typically take the supplement and report sustained changes.
Watch for interactions: Beta-blockers can reduce endogenous melatonin production; adding exogenous melatonin changes the balance in ways clinicians will want to monitor. When multiple cardiac drugs are involved, the additive effects on blood pressure or heart rate are the immediate concern — not a long-term causation claim about heart failure.
Adverse-event reporting and recall patterns for melatonin products
Dietary supplement safety events rarely mirror pharmaceutical safety pathways. RecallTracker aggregates recall notices and safety actions across {{AGENCY_LIST}} so consumers can see both clinical signals and product-quality warnings in one place. Using these datasets clarifies where melatonin-related risks are likely to arise.
Recalls and product-safety data (agency-level snapshot)
| Agency / Dataset | Recalls tracked by RecallTracker |
Mislabeling and potency variance: Laboratory testing of dietary supplements frequently reveals label–content mismatches. Products marketed as containing X mg of melatonin may contain substantially more or less. Overdosed products raise the risk of hypotension, daytime sedation, or interactions with cardiac medications.
Contamination with undeclared drugs or adulterants: When a supplement contains an unlisted pharmaceutical or other active agent, the health risk can be acute. Adulteration is the most dangerous failure mode because a consumer can unknowingly receive a drug that interacts with their cardiac medicines.
Microbial contamination and chemical contaminants: Poor manufacturing practices can permit microbial growth or leave behind solvent residues and heavy metals. These contaminants more commonly produce systemic toxicity than isolated heart failure, but in vulnerable patients they can exacerbate cardiac conditions.
Packaging and pediatric risks: Melatonin gummies and chewables are a recurring product type linked to accidental pediatric ingestion. CPSC may get involved if packaging or labeling poses a choking risk or if small parts are a hazard.
Undeclared allergens: Some melatonin products include herbal extracts or excipients not listed on the label; allergic reactions complicate cardiac care in sensitive individuals.
How recall notices reach consumers
FDA and manufacturer voluntary recalls: The FDA’s typical pathway for dietary supplements is to work with manufacturers on voluntary recalls unless regulatory enforcement (seizure, injunction) is necessary.
CPSC actions: The CPSC issues recalls for consumer product hazards (packaging, choking). When melatonin gummies or dispensing devices pose a physical hazard, CPSC notifications may appear alongside FDA posts.
Public reporting and poison-control signals: Poison control center calls and MedWatch reports sometimes precede or accompany recalls. A cluster of cardiac-related reports tied to a specific lot number or brand can trigger an investigation.
Where melatonin-related cardiac reports come from
Post-market surveillance systems such as FDA MedWatch and voluntary manufacturer reports collect adverse-event narratives. Single reports without lot numbers typically do not prompt recalls; clustered reports that point to a specific product batch or analytical evidence of contamination do.
A report of chest pain or arrhythmia after supplement use goes to adverse-event databases, but causality assessment requires clinical details, product lot testing, and epidemiologic context.
How to interpret a recall notice for melatonin
A recall for “mislabeling” does not necessarily imply a cardiac hazard; it may mean a product contains significantly more melatonin than labeled, which could produce greater hemodynamic effects in sensitive users.
A recall for “pharmaceutical adulterant” is higher risk for people on cardiac medications because undeclared drugs can interact or produce arrhythmias.
The presence of a recall in the FDA list indicates an identified problem with the product or packaging; follow the manufacturer instructions and consult your clinician if you have heart disease.
For background on how supplement recalls are initiated and what consumers should expect from the recall process, see the dietary supplement recall process and how regulators act on contamination reports related recall guide. That piece walks through the technical steps manufacturers and agencies take once a contamination signal appears.
Clinical case signals: what adverse reports say about melatonin and heart failure
Adverse-event reports and small clinical case series provide the most direct human evidence linking melatonin to cardiac symptoms — not because they prove causation, but because they indicate scenarios clinicians and consumers should watch for.
Types of cardiac events reported in association with melatonin
Bradycardia and symptomatic slow heart rate: Reported in isolated cases, often with concurrent beta-blocker use or in older adults.
Palpitations and supraventricular arrhythmias: Some reports describe palpitations or new supraventricular tachycardia temporally related to melatonin ingestion, though alternate causes (caffeine, stress, electrolyte disturbances) are frequently present.
Hypotension and presyncope: Blood-pressure declines after a nighttime melatonin dose are plausible and have been documented in controlled physiologic studies.
Worsening heart-failure symptoms: Anecdotal reports describe transient worsening of shortness of breath after starting a supplement; these reports rarely demonstrate a direct mechanistic link and often involve polypharmacy or intercurrent illness.
Why isolated reports do not equal population-level risk
Single adverse-event entries do not adjust for underlying disease prevalence, concomitant medication, or dose. A report that someone with heart failure took melatonin and then had decompensation does not prove melatonin caused the decompensation.
Laboratory confirmation and lot-linked clustering are the strongest grounds for a product-related recall. Without lot data or product analysis, causality often remains circumstantial.
What clinicians and safety analysts look for
Temporal clustering: multiple reports from independent sources pointing to the same lot or UPC suggest a product-quality problem.
Pharmacologic plausibility: evidence that the product contained an undeclared pharmacologic substance that could explain the cardiac event strengthens the link.
Dechallenge/rechallenge patterns: improvement after stopping the product (dechallenge) and recurrence on re-exposure (rechallenge) provide stronger causal signals.
Practical framing for consumers
If you have heart failure and experience new palpitations, chest pain, fainting, or persistent lightheadedness after starting melatonin, treat those symptoms as clinically significant and seek prompt evaluation.
For less severe symptoms (mild dizziness, transient palpitations), stop the supplement and contact your cardiology team for guidance and monitoring.
How to check your melatonin product for recalls and what to do if you find one
A rapid, practical checklist reduces risk and speeds any necessary medical assessment. Implement the checklist below immediately if you are concerned that a melatonin product may be linked to symptoms.
Actionable checklist: what to do now
[ ] If you have severe symptoms (chest pain, difficulty breathing, fainting, new syncope), call 911 or go to the nearest emergency department.
[ ] Stop taking the supplement immediately if you experience new or worsening cardiac symptoms.
[ ] Locate the product packaging and note the brand name, lot number, expiration date, UPC/barcode, and the date purchased.
[ ] Take a clear photograph of the front and back of the package and the lot number.
[ ] Use a barcode lookup — you can [scan a product barcode]barcode scanner with your phone to pull manufacturer and UPC details and speed recall checks.
[ ] Use the site’s brand-level search to [check recalls by brand]brand recall lookup for any notices tied to your product or lot.
[ ] Compare the lot number against recall notices and check public recall feeds (FDA, CPSC) for matching lot information.
[ ] Report the event to your clinician and to public health: file a MedWatch report with the FDA (or your country’s reporting system) and contact Poison Control if ingestion was accidental or involved a child.
[ ] Keep a sample of the supplement in a sealed container and store it safely (out of reach of children), in case public-health investigators request it for testing.
[ ] If a recall is confirmed, follow the manufacturer’s instructions: many recalls request return, destruction, or refund. Preserve proof of purchase if seeking reimbursement or follow-up.
[ ] Consider signing up for product-alert services such as RecallTracker; faster alerts reduce the time between recall issuance and consumer action. Learn more about subscription options for active monitoring, including RecallTracker Premium RecallTracker Premium.
Why the barcode and lot number matter
Lot-level data enable investigators to link clinical reports to a specific manufacturing batch. A recall limited to a single lot is very different from a market-wide removal.
UPC-level searches help identify the exact SKU, formulation, and manufacturer contact information, which expedites reporting and corrective action.
How to report an adverse event the right way
Provide specific details: brand, UPC, lot number, dose, timing relative to symptom onset, description of symptoms, medical interventions (ED visit, hospitalization), underlying cardiac diagnoses, and all concomitant medicines.
Submit to MedWatch (FDA) or to your local pharmacovigilance/poison-control system. In the U.S., providers and consumers can submit online or by phone.
Follow any additional manufacturer steps; some companies request that consumers mail a sample or photograph the product and receipt.
Where to look for authoritative recall notices
FDA safety alerts and enforcement reports — these include supplement advisory notices and lists of voluntarily recalled products.
CPSC announcements — for packaging and choking hazards, especially with gummy or chewable forms.
RecallTracker aggregates these notices so consumers can search by UPC, lot, or brand and receive alerts. Use the site’s [recall statistics]recall statistics to identify trends and monitor product categories over time.
Regulatory landscape: how FDA, CPSC, and other agencies approach melatonin supplements
Understanding which agency has jurisdiction clarifies why certain recall notices behave differently.
Who regulates what
FDA: In the United States, dietary supplements (including melatonin) are regulated under the Dietary Supplement Health and Education Act (DSHEA). The FDA oversees labeling, adulteration, and contamination issues. Most supplement recalls are voluntary actions coordinated with FDA guidance.
CPSC: Handles physical hazards associated with consumer products — e.g., packaging that allows easy child access to melatonin gummies or small parts that pose a choking risk.
State agencies and international regulators: State health departments may issue advisories, and agencies outside the U.S. (Health Canada, EU Safety Gate) publish their own recall notices. RecallTracker aggregates across {{AGENCY_LIST}} to provide a consolidated view.
Limitations of regulatory power for supplements
Voluntary recalls: The FDA generally requests voluntary recalls for dietary supplements rather than issuing mandatory recalls. Exceptions occur when imminent public-health risks or enforcement actions (seizures, court orders) are justified.
Investigation timeframe: Product analysis, traceback, and laboratory confirmation take time. Even when adverse reports arrive promptly, confirmation and a formal recall can take days to weeks.
Cross-border manufacturing and distribution complicate recalls. Many supplement manufacturers operate globally; international coordination is often necessary for effective lot-level action.
How agencies evaluate risk for cardiac events
Evidence hierarchy: Analytical confirmation (lab identification of an adulterant), clustered adverse events linked to a specific lot, and reports of severe outcomes raise the priority for recall.
Clinical input: Agencies consult clinical experts when interpreting reports that describe cardiac symptoms, especially if the affected population includes older adults or those with preexisting cardiac conditions.
What consumers should expect from a recall notice
Clear instructions: Stop use, check lot and UPC, and follow return/disposal guidance.
Manufacturer contact information: Where to request refunds or remediation.
Public-health advisories: If a product contains an undeclared pharmaceutical, public-health messages emphasize immediate discontinuation and evaluation by a clinician.
For families with children, the intersection of product safety and child-specific risks matters. For a focused review on children’s exposures, see melatonin safety for children and parental guidance related recall guide.
How to weigh the clinical evidence against product-quality signals
Two separate safety domains matter when a person with cardiac disease asks, “Should I take melatonin?”
Pharmacologic/physiologic risk from melatonin itself:
Small physiologic changes in blood pressure and heart rate can occur; the long-term effect on heart failure progression is not established.
For many patients, low-dose melatonin used intermittently for circadian issues has minimal measurable cardiac impact when used under clinician supervision.
Product-quality risk from mislabeled or contaminated supplements:
A contaminated or adulterated melatonin product can introduce pharmacologically active substances that materially increase cardiac risk.
A manufacturer recall due to contamination is an immediate safety signal that is actionable — consumers can return or stop using the product and avoid potential harm.
Clinical decision approach
If you have stable heart failure and want to trial melatonin for sleep disturbance, get individualized advice from your cardiologist. If they approve, use a single-brand, reputable product and monitor vital signs.
If you have heart failure and are using over-the-counter melatonin, prioritize confirming product quality (lot and brand checks). A recall tied to your product changes the immediate risk calculus and should prompt stopping the product and clinical review.
Research gaps and surveillance priorities into {{CURRENT_YEAR}} and beyond
Surveillance findings to prioritize
Lot-linked reporting: Better capture of lot numbers in adverse-event reports would allow faster linkage between clinical outcomes and product batches.
Analytical testing: Routine, randomized laboratory testing of finished supplement products would reduce the time between contamination and public notification.
Cardiac-specific signal monitoring: Public-health systems should flag clusters of cardiac events temporally associated with supplement use, particularly in vulnerable populations.
What evidence would change clinical practice
High-quality, adequately powered randomized clinical trials examining melatonin use in people with heart failure are needed to draw definitive conclusions about therapeutic benefit or harm.
Cohort studies using linked pharmacy/claims data could evaluate population-level associations between melatonin use and heart-failure hospitalizations or arrhythmia incidence.
Regulatory reforms that would reduce risk
Mandatory adverse-event reporting requirements for supplement manufacturers (with accessible lot-level data) would accelerate investigations.
Expanded authority to compel product recalls when analytical evidence demonstrates contamination could improve consumer protection, especially when adulterants pose acute cardiac risk.
Key takeaways for consumers concerned about melatonin and heart failure
Physiologic effects: Melatonin can lower blood pressure and influence heart rate; these effects are usually mild but can be clinically relevant in people with heart failure or on multiple cardiac medicines.
Product quality matters: Most immediate safety risks arise from mislabeled, contaminated, or adulterated supplements — situations that trigger recalls.
Use the data that exists: RecallTracker aggregates {{RECALL_COUNT}} recalls from {{AGENCY_COUNT}} agencies to help consumers find lot-level and brand-level notices quickly.
Immediate actions: For severe cardiac symptoms after taking melatonin call emergency services; for non-emergency concerns stop the product, document lot and UPC, [scan a product barcode]barcode scanner, and [check recalls by brand]brand recall lookup.
Professional oversight: Discuss melatonin use with a cardiologist if you have heart failure, atrial arrhythmia, or are taking multiple cardiac medications.
Can melatonin cause or worsen heart failure?
There is no high-quality clinical evidence that melatonin causes chronic heart failure in otherwise healthy adults. Preclinical studies show cardioprotective mechanisms, while human data are limited and largely observational. Melatonin can affect blood pressure and heart rate, so in people with advanced cardiac disease or unstable hemodynamics the supplement could theoretically worsen symptoms. If you have heart failure, consult your cardiology team before starting melatonin and monitor blood pressure and heart rate closely.
Have melatonin supplements been recalled for reasons that could affect heart health?
Yes — recalls involving melatonin products typically relate to mislabeling, potency variance, contamination, or undeclared pharmaceutical adulterants. A recall for adulteration or contamination poses a higher immediate risk for people on cardiac medications because undeclared active ingredients can interact and produce arrhythmias or hemodynamic instability. Use lot and UPC information to match your product to any recall notices; you can also use our site to [check recalls by brand]brand recall lookup and to review public recall feeds.
How do I check whether my melatonin product was recalled?
Locate the brand name, UPC/barcode, lot number, and expiration date on the package. Photograph the packaging and use a barcode tool — [scan a product barcode]barcode scanner — to retrieve manufacturer and UPC details. Then search recall lists by UPC or brand and compare lot numbers. If you find a match, follow the manufacturer’s recall instructions and consult your clinician. Reporting the event to MedWatch (FDA) and Poison Control adds clinical data that can accelerate investigations.
What symptoms after taking melatonin should prompt emergency care?
Seek immediate care (call 911 or go to the emergency department) for chest pain, severe shortness of breath, fainting or syncope, persistent lightheadedness, or sudden-onset irregular heartbeat. For milder symptoms such as transient palpitations or mild dizziness, stop the supplement and contact your clinician for guidance; retain the product packaging for possible testing.
How can I report a suspected melatonin-related adverse event?
Provide all available details — product brand, UPC, lot number, exact dose taken, timing relative to symptoms, underlying cardiac diagnoses, and any medical evaluations or hospitalizations — to the FDA’s MedWatch system (or your country’s equivalent) and to Poison Control if ingestion was accidental or involved a child. Also inform your prescribing clinicians so they can document the event and adjust treatment. For proactive monitoring, consider subscription services that alert you to lot-level recalls; options include [RecallTracker Premium]RecallTracker Premium for automated notifications and SKU-level coverage.
If you want step-by-step help matching a product UPC to recall listings, use the site’s [scan a product barcode]barcode scanner feature and then cross-reference the brand with our brand-level search to [check recalls by brand]brand recall lookup. For broader trends and year-over-year recall volumes in supplement categories, visit our [recall statistics]recall statistics dashboard to view aggregated data from {{AGENCY_LIST}} and see how supplement recalls compare across years.
Frequently Asked Questions
How do I check if my melatonin heart failure medication has been recalled?
Check the lot number on your medication packaging and scan the barcode at /scan. You can also search by brand or generic name at /brands. The FDA publishes enforcement reports that are indexed in RecallTracker's database of {{FDA_COUNT}} FDA actions.
What should I do if my melatonin heart failure product is on a recall list?
Do not stop taking prescribed medication without consulting your healthcare provider first. Contact your pharmacist to discuss alternatives and check if your specific lot number is affected. Use /brands to verify the recall scope and follow the manufacturer's instructions for returns or replacements.
What are the most common reasons melatonin heart failure products are recalled?
Common reasons include contamination with impurities (such as NDMA or other nitrosamines), incorrect dosage or potency, mislabeling, failed dissolution testing, and microbial contamination. These issues are tracked in {{RECALL_COUNT}} total recalls across all agencies. Check /statistics for drug recall trends.
How does the FDA monitor melatonin heart failure product safety?
The FDA conducts inspections of manufacturing facilities, reviews adverse event reports, and runs laboratory testing programs. When problems are found, the agency works with manufacturers on voluntary recalls or issues mandatory actions. Monitor FDA activity at /statistics and set up alerts at /pricing for your specific medications.
Can I get a refund for recalled melatonin heart failure products?
Most recall notices include instructions for returns or refunds through the manufacturer or your pharmacy. Keep your receipt and the original packaging as proof of purchase. Check the specific recall details at /brands for the manufacturer's contact information and refund process.